1-3 of 3
Agnieszka Barchnicka
Close
Sort by
Journal Articles

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Grzegorz Charlinski, MDPhD, Agata Tyczyńska, MD, Jan M Zaucha, MD PhD, Adriana Czyz, MD, Jarosław Czyż, MDPhD, Dominik Dytfeld, MDPhD, Bartosz Malecki, MD, Lidia Gil, MDPhD, Szymon Fornagiel, MD, Sebastian Grosicki, MD PhD, Agnieszka Barchnicka, MD, Jadwiga Holojda, MD, Agnieszka Kolkowska, MD PhD, Iwona Hus, MD PhD, Grzegorz Helbig, MDPhD, Anna Kopinska, MD, Anna Masternak, MD, Dariusz Woszczyk, MDPhD, Miroslaw Markiewicz, MDPhD, Jaroslaw Piszcz, MDPhD, Janusz Kloczko, MDPhD, Lidia Usnarska-Zubkiewicz, MDPhD, Tomasz Wrobel, MD PhD, Pawel J. Robak, MDPhD, Tadeusz Robak, MDPhD, Anna Waszczuk-Gajda, MD, Grzegorz Basak, MD PhD, Artur Jurczyszyn, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-143003
Published: 2020
Journal Articles

The Survival Of The Elderly Acute Myeloid Leukemia Patients Do Not Depend On The Intensity Of Induction Chemotherapy. Retrospective Study Results

Sebastian Grosicki, MD, Ewa Bodzenta, Marek Kriegler, Ilona Szypula, Marcin Fejklowicz, Maja Twardosz, Teresa Kurzawa, Agnieszka Barchnicka, Aleksandra Melisz
Journal: Blood
Blood (2013) 122 (21): 5029.
https://doi.org/10.1182/blood.V122.21.5029.5029
Published: 2013
Journal Articles

Comparable Toxicity and Outcome of Acute Myeloid Leukemia (AML) Fit Patients Therapy Independently If Daunorubicin or Idarubicin Were Added to Cytarabine/Cladribine Induction Regimens – the Single Centre Study

Sebastian Grosicki, MD, PhD, Marek Kriegler, Ewa Bodzenta, Maja Twardosz, Ilona Szypula, Marcin Fejklowicz, Olga Haus, MD, PhD, Teresa Kurzawa, Agnieszka Barchnicka
Journal: Blood
Blood (2012) 120 (21): 4337.
https://doi.org/10.1182/blood.V120.21.4337.4337
Published: 2012